Mortality in pneumonia and acute respiratory distress syndrome is significantly affected by corticosteroid treatment, emphasizing careful consideration.
Key evidence shows systemic corticosteroids are linked to increased infection rates among pneumonia cases, indicating healthcare implications.
Observational analysis highlights the relationship between corticosteroids and mortality within pneumonia and acute respiratory distress syndrome populations.
Findings call for further investigation into corticosteroid therapy's role in pneumonia and acute respiratory distress syndrome treatment.